8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a DPP inhibitor

Details for Australian Patent Application No. 2005219508 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Himmelsbach, Frank; Eckhardt, Matthias; Thomas, Leo; Tadayyon, Mohammad; Langkopf, Elke

Agent Davies Collison Cave

Pub. Number AU-B-2005219508

PCT Pub. Number WO2005/085246

Priority DE 10 2004 032 263.5 03.07.04 DE; DE 10 2004 012 921.5 17.03.04 DE; DE 10 2004 008 112.3 18.02.04 DE

Filing date 12 February 2005

Wipo publication date 15 September 2005

Acceptance publication date 16 February 2012

International Classifications

C07D 473/04 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/085246 Priority application(s): WO2005/085246

16 February 2012 Application Accepted

  Published as AU-B-2005219508

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005219510-Skin lightening agents, compositions and methods

2005219507-Pyrrole-derivatives as factor Xa inhibitors